More tumor mutations equals higher success rate with cancer immunotherapy drugs – Medical Xpress
Medical Xpress |
More tumor mutations equals higher success rate with cancer immunotherapy drugs
Medical Xpress More tumor mutations equals higher success rate with cancer immunotherapy drugs. Credit: The New England Journal of Medicine. The mutational burden, or the number of mutations present in a tumors DNA, is a good predictor of whether that cancer type … |
